Patent: 10,105,356

Summary for Patent: 10,105,356

Title:	Aerosol pirfenidone and pyridone analog compounds and uses thereof
Abstract:	Disclosed herein are formulations of pirfenidone or pyridone analog compounds for aerosolization and use of such formulations for aerosol administration of pirfenidone or pyridone analog compounds for the prevention or treatment of various fibrotic and inflammatory diseases, including disease associated with the lung, heart, kidney, liver, eye and central nervous system. In some embodiments, pirfenidone or pyridone analog compound formulations and delivery options described herein allow for efficacious local delivery of pirfenidone or pyridone analog compound. Compositions include all formulations, kits, and device combinations described herein. Methods include inhalation procedures, indications and manufacturing processes for production and use of the compositions described.
Inventor(s):	Surber; Mark William (San Diego, CA)
Assignee:	Avalyn Pharma Inc. (Seattle, WA)
Application Number:	13/950,110
Patent Claims:	see list of patent claims

Details for Patent 10,105,356

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Biogen Inc.	AVONEX	interferon beta-1a	For Injection	103628	May 17, 1996	10,105,356	2033-07-24
Biogen Inc.	AVONEX	interferon beta-1a	Injection	103628	May 28, 2003	10,105,356	2033-07-24
Biogen Inc.	AVONEX	interferon beta-1a	Injection	103628	February 27, 2012	10,105,356	2033-07-24
Emd Serono, Inc.	REBIF	interferon beta-1a	Injection	103780	March 07, 2002	10,105,356	2033-07-24
Emd Serono, Inc.	REBIF	interferon beta-1a	Injection	103780	December 17, 2004	10,105,356	2033-07-24
Emd Serono, Inc.	REBIF	interferon beta-1a	Injection	103780	December 21, 2012	10,105,356	2033-07-24